March 8, 2018 / 7:23 AM / 7 months ago

BRIEF-N4 Pharma Names Andrew Leishman As Head Of Nuvec Development

March 8 (Reuters) - N4 Pharma Plc:

* SAYS ANNOUNCES APPOINTMENT OF ANDREW LEISHMAN AS HEAD OF NUVEC DEVELOPMENT

* SAYS COMPANY IS PROACTIVELY LOOKING TO WORK WITH PARTNERS TO EVALUATE ITS NUVEC SYSTEM WITH THEIR PRODUCTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below